Hope Hp‐GC Project—Program Implementation for Primary and Secondary Prevention of Gastric Cancer in Latin America
Helicobacter · 2026
DOI: 10.1111/hel.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Helicobacter, 2026. Verfasst von Javier Uribe und 36 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter Infections, Secondary Prevention, Primary Prevention. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: World Health Organization, Centro Para la Prevención y Control del Cáncer (CECAN) ANID-FONDAP, Biohit Oyj.
Abstract (Originalsprache)
Introduction
Gastric cancer (GC) is the fifth leading cause of cancer‐related mortality globally; its main burden is concentrated in East Asia and some areas of Europe and Latin America. This study aims to develop an organized and structured GC prevention pilot program in intermediate‐to‐high‐incidence countries in Latin America.
Methods
This study involved two strategies: (a) primary prevention for screen‐and‐treat H. pylori infection among individuals aged 30–39 years ( n = 7500, 500 in 15 sites), and (b) primary and secondary prevention for individuals aged 40–75 years ( n = 9600, 600 in 16 sites) with tiered risk stratification using an algorithm developed and validated in Chile (Gastrocalc: priority 1 to 6; age, sex, hypertension, IgG H. pylori , pepsinogen I and II, and Gastrin‐17b), and high‐quality esophagogastroduodenoscopy (EGD) evaluation.
Results
Pilot phases were successfully conducted in Chile and Colombia during 2023–2025. In Chile (Molina), 4152 asymptomatic individuals were tested with H. pylori prevalence of 46% ( n = 113/246) in 2023, 34% ( n = 504/1484) in 2024, and 32% ( n = 609/1904) in 2025. The H. pylori prevalence among individuals aged 30–39 years (592/4152; 14.3%) was 37.8%. In Colombia, 1250 asymptomatic individuals were screened across four regions; in 2025, the prevalence of H. pylori among individuals aged 30–39 years was 69% ( n = 895/1250). The validation of Gastrocalc included 866 individuals from 5 regions in Chile. The algorithm successfully identified 80.6% of OLGA III–IV patients and 100% of GC patients (Priority 1–4). Other countries will start activities in 2026.
Conclusions
This pioneering study will advance understanding and feasibility of urgently needed primary and secondary prevention for GC in Latin America.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Instituto de Medicina, Red Salud UC Christus, Santiago, Chile.
- Estudiante de Maestría en Epidemiología, Pontificia Universidad Javeriana, Cali, Colombia.
- Grupo de Investigación en Infecciones y Cáncer (GINFYCA), Centro de Investigaciones Clínicas, Fundación Hospital San Pedro, Pasto, Colombia.
- Grupo de Investigación en Ciencia y Salud (GICIENSA), Facultad de Ciencias de la Salud, Programa de Medicina, Universidad de Nariño, Pasto, Nariño, Colombia.
- Departamento de Medicina Interna, Pontificia Universidad Católica de Chile, Santiago, Chile.
ORCID-Profile: Javier Uribe, José Darío Portillo-Miño, Gonzalo Latorre, Diego Reyes-Placencia, Mauricio Pizarro, Alberto Espino, Felipe Silva, José M Remes-Troche, Dacio Cabrera, Alejandro Piscoya, Juan Ramírez, Douglas Morgan, Manuel Espinoza, Shailja C Shah, Jin Young Park, M Constanza Camargo, Arnoldo Riquelme
Förderung
- World Health Organization
- Centro Para la Prevención y Control del Cáncer (CECAN) ANID-FONDAP
- Biohit Oyj
Zitieren
APA
Uribe, J., Portillo-Miño, J. D., Latorre, G., Reyes-Placencia, D., Pizarro, M., Vargas, J. I., Espino, A., Jure, C., Pizarro, M., Bofill, G., Silva, F., Palacios, N., Díaz-Garrido, N., Huidobro, L., Araya, R., Ledesma, S., Otero, W., Otero, L., Remes-Troche, J. M., …, & Task Force HOPE Hp‐GC Project Consortium (2026). Hope Hp‐GC Project—Program Implementation for Primary and Secondary Prevention of Gastric Cancer in Latin America. Helicobacter. https://doi.org/10.1111/hel.70109
Vancouver
Uribe J, Portillo-Miño JD, Latorre G, Reyes-Placencia D, Pizarro M, Vargas JI, et al. Hope Hp‐GC Project—Program Implementation for Primary and Secondary Prevention of Gastric Cancer in Latin America. Helicobacter. 2026. doi:10.1111/hel.70109
BibTeX
@article{Uribe2026,
author = {Uribe, Javier and Portillo-Miño, José Darío and Latorre, Gonzalo and Reyes-Placencia, Diego and Pizarro, Mauricio and Vargas, José Ignacio and Espino, Alberto and Jure, Camila and Pizarro, Margarita and Bofill, Gabriela and Silva, Felipe and Palacios, Nilton and Díaz-Garrido, Natalia and Huidobro, Laura and Araya, Raúl and Ledesma, Sergio and Otero, William and Otero, Lina and Remes-Troche, José M and Campos, Christian and Largacha, Monserrate and Varas, Oscar and Cabrera, Dacio and Piscoya, Alejandro and Ramírez, Juan and Laudanno, Oscar and Esteves, Sebastián and Cifuentes, Sandra and García, Eduardo and María-Guzmán, Ana and Morgan, Douglas and Espinoza, Manuel and Shah, Shailja C and Park, Jin Young and Camargo, M Constanza and Riquelme, Arnoldo and Task Force HOPE Hp‐GC Project Consortium, Task Force HOPE Hp‐GC Project Consortium},
title = {Hope Hp‐GC Project—Program Implementation for Primary and Secondary Prevention of Gastric Cancer in Latin America},
journal = {Helicobacter},
year = {2026},
doi = {10.1111/hel.70109}
}
EUVIMED